Johnson, Braden, Tony Pham, Kate Young, Leonidas Bantis, Weijing Sun, and Anup Kasi. “Epidermal Growth Factor Receptor Inhibitor Treatment Timing Does Not Impact Survival in Stage 4 Colon Cancer Treatment: A Retrospective Study: EGFR Inhibitor Treatment Line Outcomes”. Kansas Journal of Medicine 15, no. 2 (August 22, 2022): 273–277. Accessed July 17, 2024. https://journals.ku.edu/kjm/article/view/15975.